Enhanced O-linked Glcnacylation in Crohn's disease promotes intestinal inflammation
Background: Treatment of Crohn's disease (CD) remains to be a challenge due to limited insights for its pathogenesis. We aimed to determine the role of O-Linked β-N-acetylglucosamine (O-GlcNAc) in the development of CD and evaluate therapeutic effects of O-GlcNAc inhibitors on CD. Methods: O-Gl...
Main Authors: | Qian-Hui Sun, Yi-Shu Wang, Guolong Liu, Hong-Lan Zhou, Yong-Ping Jian, Ming-Di Liu, Dan Zhang, Qiang Ding, Rui-Xun Zhao, Jian-Feng Chen, Yi-Ning Li, Jiyong Liang, Yu-Lin Li, Cheng-Shi Quan, Zhi-Xiang Xu |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-03-01
|
Series: | EBioMedicine |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2352396420300682 |
Similar Items
-
Deficiency in intestinal epithelial O‐GlcNAcylation predisposes to gut inflammation
by: Ming Zhao, et al.
Published: (2018-08-01) -
Chemistry-Assisted Proteomic Profiling of O-GlcNAcylation
by: Qiang Zhu, et al.
Published: (2021-06-01) -
O-GlcNAcylation and inflammation: a vast territory to explore
by: Léa eBaudoin, et al.
Published: (2015-01-01) -
Blockage of O-linked GlcNAcylation induces AMPK-dependent autophagy in bladder cancer cells
by: Lu Jin, et al.
Published: (2020-03-01) -
O-GlcNAcylation links ChREBP and FXR to glucose-sensing
by: Fadila eBenhamed, et al.
Published: (2015-01-01)